Erika Hamilton

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Erika Hamilton
Mar 24, 2025, 10:29 | Blog
Erika Hamilton: Registration is open for the 24th Annual International Congress on the Future of Breast Cancer East
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Mar 12, 2025, 06:49 | Blog
Erika Hamilton: Planning ASCO25 scientific program
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Mar 11, 2025, 12:26 | Blog
Erika Hamilton: JSMO25 was amazing
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Mar 9, 2025, 12:46 | Blog
Erika Hamilton: A fantastic meeting with our colleagues across Asia at JSMO 2025
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Jan 23, 2025, 19:05 | Blog
Erika Hamilton: ASCO25 abstract deadline is 5 days away
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Jan 23, 2025, 14:32 | Blog
Erika Hamilton: A true team at Sarah Cannon Research Institute
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Jan 19, 2025, 07:17 | Science
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer
Dana-Farber’s Breast Oncology Center posted on X, about recent paper by Kevin Kalinsky et al.,…
Jan 15, 2025, 15:57 | Positive
William Pao: Breakthrough - The Quest for Life-Changing Medicines
William Pao, Chief Executive Officer of Revelio Therapeutics, shared a post on LinkedIn: "Today is…
Jan 8, 2025, 11:37 | Blog
Aakash Desai: Sacituzumab govitecan continues to show promise as a 2-line treatment for extensive-stage SCLC
Aakash Desai, Assistant Professor at UAB O’Neal Comprehensive Cancer Center, shared on LinkedIn: "Sacituzumab govitecan…
Jan 4, 2025, 15:18 | Insight
Vivek Subbiah: Top Phase 1 clinical trial publications of 2024
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…
Dec 28, 2024, 15:46 | Drugs
Paolo Tarantino: Dato-DXd is now approved in Japan for HR+/HER2- MBC
Paolo Tarantino, Research fellow at Dana-Farber Cancer Institute and Harvard Medical School, shared a post…
Dec 27, 2024, 10:48 | Drugs
Raffaele Colombo: Dato-DXd approved in Japan for HR+, HER-negative unresectable or recurrent breast cancer
Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared on X: “Datopotamab deruxtecan (dato-DXd)…
Dec 26, 2024, 15:50 | Insight
Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: “Here’s the most recent Breast Cancer…
Dec 24, 2024, 14:02 | Science
Stephanie Graff: Abemaciclib Plus Fulvestrant in Advanced Breast Cancer
Stephanie Graff, Director of Breast Oncology at Brown University Health, posted on X about recent…
Dec 23, 2024, 12:23 | Science
Paolo Tarantino: PostMONARCH is out in Journal of Clinical Oncology
A recent paper by Kevin Kalinsky, Director of the Glenn Family Breast Center at Winship,…
Dec 20, 2024, 02:13 | Blog
Erika Hamilton: Honored to have been elected to the ASCO Nominating Committee
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Dec 19, 2024, 21:27 | Blog
Robin Zon: ASCO25 is sure to inform, inspire and innovate!
Robin Zon , President of ASCO for 2024-2025, shared a post by Erika Hamilton, Director…
Dec 19, 2024, 14:18 | Blog
ACSBCN - Learning about the latest advancements in breast cancer research in SABCS
American Cancer Society National Breast Cancer Roundtable shared on LinkedIn: "ACS NBCRT Strategic Director, Melissa…
Dec 16, 2024, 17:51 | Insight
Best of 2024 SABCS - San Antonio Breast Cancer Symposium
The SABCS 2024 (San Antonio Breast Cancer Symposium) took place from December 10th to 13th,…
Dec 16, 2024, 04:11 | Insight
Highlights from Day 4 of SABCS 2024
The SABCS 2024 (San Antonio Breast Cancer Symposium) took place from December 10th to 13th,…
Dec 15, 2024, 08:06 | Blog
Erika Hamilton: Advancing breast cancer care at SABCS
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Dec 14, 2024, 13:35 | Blog
Arif Kamal: Only 7% of adults with a cancer diagnosis enroll in a therapeutic clinical trial
Arif Kamal, Chief Patient Officer for the American Cancer Society, shared a post on LinkedIn:…
Dec 14, 2024, 01:08 | Blog
Erika Hamilton: Does remote symptom monitoring improve fatigue in MBC?
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Dec 13, 2024, 22:22 | Blog
SABCS24 Day 3 Highlights from Oncology Brothers
Oncology Brothers shared a post on X: "SABCS24 Day 3 Highlights  1. EUROPA: ET vs…
Dec 13, 2024, 19:52 | Blog
Insights on EMBER3 trial from SABCS 2024
Imlunestrant has been approved for the treatment of breast cancer. It is a next-generation, brain-penetrant,…
Dec 13, 2024, 18:46 | Blog
Erika Hamilton: For those healthy enough for surgery, do it in cases of breast cancer
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Dec 13, 2024, 16:47 | Insight
Erika Hamilton presented results from a post-hoc exploratory analysis of the NATALEE trial at SABCS24
TRIO - Translational Research in Oncology shared a post on LinkedIn: “TRIO News from SABCS2024!…
Dec 13, 2024, 14:30 | Insight
Day 2 Highlights of SABCS24 by Erika Hamilton
The San Antonio Breast Cancer Symposium (SABCS) 2024 is taking place from December 10-13 in…
Dec 13, 2024, 05:58 | Blog
Erika Hamilton: Risk reducing surgery in young BRCA carriers with a prior Breast Cancer, by Matteo Lambertini
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Dec 13, 2024, 05:49 | Insight
Highlights from Day 3 of SABCS 2024
The SABCS 2024 (San Antonio Breast Cancer Symposium) is taking place from December 10th to…
Dec 12, 2024, 14:12 | Blog
SABCS24 Day 2 Highlights from Oncology Brothers
Oncology Brothers posted on X: "SABCS24 Day 2 Highlights 1. EMBER3: Oral SERD in HR+…
Dec 12, 2024, 13:36 | Blog
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
Erika Hamilton, The Director of Breast Cancer Program at Sarah Cannon Research Institute, shared on…
Dec 11, 2024, 19:12 | Insight
Highlights from Day 1 of SABCS 2024
The SABCS 2024 (San Antonio Breast Cancer Symposium) is taking place from December 10th to…
Dec 11, 2024, 17:38 | Blog
SABCS24 Day 1 Highlights by Oncology Brothers
Oncology Brothers shared a post on X: "SABCS24 Day 1 Highlights CommunityOnc: FDA Oncology Reviews recent…
Dec 10, 2024, 16:07 | Opinion
Breast Cancer Research Digest by Dana-Farber Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared on X: “Here’s the Breast Cancer Research Digest - a…
Dec 9, 2024, 16:49 | Insight
Erika Hamilton: ADCs are changing breast cancer care
Erika Hamilton, Director of Breast Cancer Program at Sarah Cannon Research Institute, shared on LinkedIn:…
Dec 3, 2024, 18:34 | Insight
Toxicity check for commonly used ADCs with Erika Hamilton and Tian Zhang
Oncology Brothers shared a post on X: “Approval is just a start, managing AEs for…
Nov 30, 2024, 22:15 | Blog
Giampaolo Bianchini: Cast your vote in the ASCO 2025 election
Giampaolo Bianchini, Head of the Translational and Immunotherapy Research Group at the San Raffaele Scientific…
Nov 28, 2024, 18:17 | Blog
SABCS's Social Media Ambassadors 2024
The SABCS 2024 (San Antonio Breast Cancer Symposium) will feature a group of Social Media…
Nov 24, 2024, 17:23 | Blog
ASCO is offering payment waivers to first authors from low-income and lower-middle-income countries
ASCO (American Society of Clinical Oncology) shared on X: "Did you hear the news? To support…
Nov 22, 2024, 16:40 | Blog
Voting in the ASCO Election is open until December 3
Erika Hamilton, Chair, Executive Committee Breast and Breast Program Lead at Sarah Cannon Research Institute,…
Nov 21, 2024, 16:00 | Blog
Mark E. Cooper will be joining SCRI to help coordinate a comprehensive breast program
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Nov 15, 2024, 16:18 | Opinion
Erika Hamilton: Harold Burstein and Thomas Grinda on anthracyline use in early breast cancer
Erika Hamilton, the Director of Breast Cancer Program at Sarah Cannon Research Institute, shared on LinkedIn: "Harold…
Nov 13, 2024, 11:34 | Blog
Erika Hamilton: Inspired by the strength of the veteran patients and their commitment to continue fighting
Erika Hamilton shared on LinkedIn: "Today, I want to take a moment to honor and thank…
Nov 12, 2024, 18:55 | Insight
María Natalia Gandur Quiroga: Just cast my vote for the ASCO election
María Natalia Gandur Quiroga, Coordinator in charge of the Urological Clinical Service of the Angel…
Nov 11, 2024, 22:32 | Blog
Vivek Subbiah: ASCO elections are open! Delighted to endorse Erika Hamilton
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…
Nov 11, 2024, 02:47 | Insight
Erika Hamilton - Candidate for ASCO Nominating Committee
Erika Hamilton has been nominated as the Undesignated Member Candidate of the nomination committee for…
Nov 10, 2024, 15:34 | Blog
Erika Hamilton: ASCO25 abstracts are open!
Erika Hamilton, the Director of Breast Cancer Program at Sarah Cannon Research Institute, shared a…
Nov 10, 2024, 13:41 | Blog
The most recent Breast Cancer Research Digest by Dana-Farber Cancer Institute
Dana-Farber’s Breast Oncology Center shared on X: "Check out the Breast Cancer Research Digest -…
Nov 7, 2024, 16:16 | Blog
Rohit Gosain: Excited to see these outstanding ASCO candidates
Rohit Gosain, Co-Host of Podcast Oncology Brothers, shared a post on LinkedIn: "It's crucial to…
Nov 5, 2024, 15:51 | Blog
Paolo Tarantino: Honored to moderate the SABCS 2024 People’s Choice session
Paolo Tarantino posted on X: "Honored to moderate the SABCS 2024 People’s Choice session on…
Nov 4, 2024, 13:32 | Insight
Paolo Tarantino: The SERENA-2 phase 2 trial of camizestrant vs fulvestrant is out
Paolo Tarantino, Research Fellow at The Dana-Farber Cancer Institute, shared on X: “The SERENA-2 phase…
Nov 4, 2024, 13:28 | Insight
Strategies to prevent and manage antibody-drug conjugate-associated nausea and vomiting
Sarah Cannon Docs shared a post on X: “SCRI breast cancer expert Erika Hamilton, joins…
Nov 2, 2024, 12:01 | Positive
Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024
As Pink October has ended, it's time to reflect on Breast Cancer Awareness Month. OncoDaily…
Oct 28, 2024, 08:58 | Insight
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Oct 26, 2024, 10:40 | Blog
Erika Hamilton: The latest advances and controversial topics in the field of breast and gynecological cancers
Erika Hamilton, Medical oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Oct 23, 2024, 13:56 | Blog
Erika Hamilton: The latest breast cancer trends
Erika Hamilton shared on Linkedin: ''When it comes to breast cancer, we face both progress…
Oct 23, 2024, 13:33 | Blog
Erika Hamilton: Clinical trials should be the first option in fighting cancer not the last
Erika Hamilton shared a post by Sarah Cannon Research Institute on LinkedIn, adding: ''At Sarah…
Oct 22, 2024, 23:50 | Blog
Why clinical trials are essential to delivering patient-centered care - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "October is Patient-Centered Care Awareness Month.…
Oct 15, 2024, 00:26 | Blog
Erika Hamilton: Happy to see ASCO's commitment to serving all
Erika Hamilton shared a post by CS Pramesh, Chairman, Tata Memorial Hospital, on X, adding: "Agree, so…
Oct 14, 2024, 18:23 | Blog
Erika Hamilton on WKRN News 2 about common myths about breast cancer
Erika Hamilton shared a post on LinkedIn: "Happy to talk to Blake Eason this morning on…
Oct 12, 2024, 12:57 | Blog
Jenna Fischer's recent breast cancer battle inspires a conversation around early detection and stage 1 triple positive breast cancer treatment - SCRI
SCRI (Sarah Cannon Research Institute) shared a post on LinkedIn: "Important Update: We hope you had…
Oct 11, 2024, 12:32 | Blog
Erika Hamilton: Reflecting on breast cancer research and the importance of clinical trials
Erika Hamilton posted the following on LinkedIn: “Many of us can recall a time in…
Oct 10, 2024, 15:23 | Blog
Erika Hamilton: The Importance of Mammograms - Early Detection Saves Lives
Erika Hamilton shared a post on LinkedIn: "Many of us can recall a time in our…
Oct 6, 2024, 16:50 | Blog
Erika Hamilton: Happy to support Breast Cancer at More than Pink walk
Erika Hamilton shared on LinkedIn: "Happy to support Breast Cancer this morning in Nashville at Susan…
Sep 29, 2024, 09:50 | Blog
Erika Hamilton: ESMO Breast 2025 submission site is now open
Erika Hamilton shared on LinkedIn: "ESMO Breast 2025 submission site is now open. Will be…
Sep 26, 2024, 11:12 | Blog
Vivek Subbiah: Incredibly excited to team up and be featured in the national news on World Cancer Research Day
Vivek Subbiah shared a post on X: "Today is World Cancer Research Day! We are incredibly…
Sep 25, 2024, 12:13 | Insight
World Cancer Research Day 2024: Innovation, Hope, and Progress in the Fight Against Cancer
This year World Cancer Research Day's theme is 'Innovation in Cancer Research Drives Progress Toward…
Sep 24, 2024, 10:36 | Blog
Vivek Subbiah: Live news segment on cutting-edge oncology progress with Erika Hamilton
Vivek Subbiah shared a post on LinkedIn: ''Bright and early! Just recorded a live news…
Sep 23, 2024, 14:23 | Blog
Tatiana Prowell: Ribociclib is now FDA-approved for stage 2 and 3 hormone receptor positive, HER2 negative breast cancer
Erika Hamilton shared on X by Tatiana Prowell, additing: ''Well isn't this a gift for…
Sep 19, 2024, 04:32 | Societies
Best of ESMO24
The ESMO Congress 2024 took place in Barcelona, from September 13 to 17, 2024, at…
Sep 17, 2024, 18:36 | Blog
Erika Hamilton: Masterful discussion of ILD with TDXd by Pat LoRusso
Erika Hamilton shared a post on X: "Masterful discussion of ILD with TDXd by Dr.…
Sep 17, 2024, 16:37 | Blog
Erika Hamilton: KN522 OS data shows 5% overall survival improvement in TNBC with pembrolizumab
Erika Hamilton posted the following on Twitter: “KN522 OS data 5 years after the initial pCR…
Sep 16, 2024, 16:31 | Societies
40 Posts Not To Miss From ESMO24 Day 3
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 16, 2024, 15:29 | Societies
Erika Hamilton's Highlights from ESMO24
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 15, 2024, 01:23 | Insight
Erika Ruiz-Garcia: Contributing to the creation and development of the ASCO 2025 Annual Meeting Program
Erika Ruiz-Garcia, Chief of the Translational Medicine Laboratory at the National Institute of Cancerology in Mexico…
Sep 14, 2024, 17:15 | Societies
45 Posts not to miss from ESMO24 Day 1
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at…
Sep 14, 2024, 00:00 | Insight
Komal Jhaveri: The triplet with fulvestrant backbone yielded a mPFS of 35 months in HER2-negative breast cancer
Komal Jhaveri, Patricia and James Cayne Chair for Junior Faculty, Associate Member, Breast Medicine and…
Sep 13, 2024, 08:31 | Blog
Robin Zon: Incredible day at ASCO HQ with Cardinale B. Smith as ASCO25 Education Chair
Robin Zon shared a post on X: ''Incredible day at ASCO HQ with Dr. Cardinale B.…
Sep 13, 2024, 04:43 | Insight
Robin Zon: Appreciate the leadership of Cardinale Smith
Robin Zon shared a post by Cardinale B. Smith, Vice President of Cancer Clinical Services…
Sep 12, 2024, 09:08 | Blog
Erika Hamilton: Fantatsic time working on ASCO25 education program
Erika Hamilton shared on LinkedIn: "Fantatsic time at American Society of Clinical Oncology (ASCO) headquarters…
Sep 10, 2024, 02:20 | Insight
William Pao: The trajectory from laboratory to your neighborhood pharmacy rarely runs in a straight line
  Erika Hamilton shared a post by William Pao, on LinkedIn, adding: “So excited to…
Sep 4, 2024, 14:06 | Blog
Erika Hamilton: Happy to join the panel of FDA-ASCO
Erika Hamilton, Breast Executive Committee Director at Sarah Cannon Research Institute, shared a post on…
Aug 25, 2024, 13:09 | Blog
Allison Zibelli and Erika Hamilton discussing data from the DESTINY-Breast06 and A-BRAVE trials
Sidney Kimmel Comprehensive Cancer Center at Jefferson shared a post on LinkedIn: "Dr. Allison Zibelli,…
Aug 7, 2024, 16:50 | Blog
The recipients of the 2024 ESMO Society Awards
The 2024 ESMO Society Awards have been announced on 6th August by ESMO. ESMO recently…
Jul 31, 2024, 03:15 | Blog
Erika Hamilton: Happy to get the word out about the VERITAC2 trial
Erika Hamilton posted on LinkedIn about a recent paper, titled "VERITAC-2: a Phase III study of…
Jul 27, 2024, 22:17 | Insight
Commentary led by Marleen Kok highlights all questions in early TNBC post-KN522
Erika Hamilton shared on X: "This commentary led by Marleen Kok highlights all the pertinent…
Jul 26, 2024, 15:07 | Blog
Erika Hamilton: Registration for Great Debates and Updates in Women's Oncology is now open
Erika Hamilton shared a post on LinkedIn: ''Are you registered for Great Debates and Updates…
Jul 26, 2024, 13:06 | Blog
Register for the 13th Asia-Pacific Breast Cancer Summit in Singapore
13th Asia-Pacific Breast Cancer Summit 2025 shared a post on LinkedIn: "Please join us at…
Jul 26, 2024, 00:18 | Blog
Erika Hamilton: Join us in Nashville for updates in Women's Oncology
Erika Hamilton shared on X: "Join us in Nashville for updates in Women's Oncology. BCSM…
Jul 19, 2024, 22:55 | Blog
Potential of "smart warheads" in oncology - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Exciting developments in cancer treatment! Erika…
Jul 19, 2024, 08:35 | Blog
Oncoinfluencers to Follow on Social Media: Dr. Erika Hamilton
As our next oncoinfluencer we are excited to feature Dr. Erika Hamilton, a prominent medical…
Jun 29, 2024, 09:05 | Blog
Erika Hamilton: Always worth major celebration when we see survival improve by 10 months in metastatic cancer
Erika Hamilton shared a post by Healthbook on LinkedIn, adding: "Always worth major celebration when we…
Jun 28, 2024, 06:15 | Blog
The American Journal of Managed Care highlights the latest research from Erika Hamilton
Sarah Cannon Research Institute shared the following post on LinkedIn: “AJMC - The American Journal…
Jun 24, 2024, 13:33 | Blog
Erika Hamilton's insights into the future of ADCs in oncology - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared the following post on LinkedIn: “We are thrilled to share…
Jun 21, 2024, 14:07 | Blog
Rahul Gosain: Breast Cancer Highlights from ASCO24 with Erika Hamilton
Rahul Gosain shared on LinkedIn:                . "Breast Cancer…
Jun 10, 2024, 10:16 | Societies
It is humbling to present trials that advance care for patients to our colleagues from across the world - SCRI Oncology Partners
SCRI Oncology Partners recently shared on LinkedIn: "SCRI Oncology Partners and Sarah Cannon Research Institute…
Jun 7, 2024, 09:11 | Insight
Erika Hamilton: Happy to share the publication in Annals of Oncology
Erika Hamilton shared a post on X: “Happy to share the publication in Annals of…
Jun 7, 2024, 00:29 | Societies
Erika Hamilton: I am leaving ASCO24 filled with renewed energy and inspiration
Erika Hamilton shared a post on LinkedIn: "ASCO24 did not disappoint! So appreciative of Lynn…
Jun 6, 2024, 14:33 | Blog
Erika Hamilton: Thanks for fantastic ASCO24 leadership
Erika Hamilton shared on X/Twitter: "Thanks to Lynn Schuchter, Angie DeMichele, and Thomas LeBlanc for fantastic…
12
All: 159 Posts: 1 - 100
Special Coverage